Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 1999

View Archived Issues

Genzyme Molecular Oncology reports Q2 1999 highlights

Important objectives achieved during Q2 at Alza

Avant Immunotherapeutics' rotavirus vaccine effective in infants

Abbott signs paclitaxel agreement with NaPro BioTherapeutics

Approval of Busulfex injection in Canada

Atugen Biotechnology establishes North American subsidiary

Targeted Genetics and Elan form drug delivery partnership

Inhibitex's U.S. patent for S. aureus attachment gene allowed

Irinotecan approved as first-line treatment for advanced colorectal cancer in Europe

EntreMed cleared to begin phase I trials of Endostatin protein

Novo Nordisk describes new K(ATP) channel-modulating series

Abbott prepares potent, selective neuronal nicotinic acetylcholine receptor ligands

Japanese investigators discover novel antitumor/antimicrobial agent produced by actinomycete

New muscarinic compounds from Alcon especially useful for Rx of glaucoma

AHP describes synthesis and activity of novel estrogenic compounds

Anthranilide anticoagulants developed by Schering AG researchers

Genetics Institute discovers and characterizes novel bone morphogenetic proteins

Millennium obtains patent coverage for novel weight-regulating compounds

Disaccharide ester with anti-TNF-alpha effects and chemopreventive efficacy

PABSA: preclinical profile of a newly developed nonpeptide ET antagonist

No adverse influence on cardiac repolarization seen in in vitro studies with tegaserod

Adolor and SmithKline Beecham sign licensing agreement for ADL-2-1294

Cangene product for prevention of hemolytic disease approved in U.K.

New thrombin inhibitor approved in Italy for antithrombotic prophylaxis

Marked, long-lasting neuroprotective effects demonstrated for NXY-059 in rats

FDA approves SB's Kytril for prevention of radiation-induced nausea and vomiting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...